Cafepharma Today

May 14 2025 - AbbVie pays ADARx $335M cash for next-gen siRNA options
AbbVie pays ADARx $335M cash for next-gen siRNA options
Novo Nordisk inks $2.2B deal for Septerna's preclinical obesity programs
Roche reports final overall survival outcomes from breast cancer treatment trial
GSK buys phase III–ready liver drug in potential $2B deal to play in MASH arena
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

PharmAthene, Siga Technologies Could Soar on Judge's Ruling
Seeking Alpha
Tuesday, June 21, 2011 - 10:28am
tags:
PharmAthene, SIGA technologies
GSK HIV Drug Pipeline Sees Boost as Partner Concert Steers to Clinical Trials
Motley Fool
Tuesday, June 21, 2011 - 10:25am
tags:
GSK, HIV, Concert Pharmaceuticals, CTP-298
Biotest, Abbott in Pact to Develop, Commercialize Antibody
Bloomberg
Tuesday, June 21, 2011 - 10:20am
tags:
Biotest Pharmaceuticals, Abbott Laboratories, antibodies, arthritis, psoriasis, BT-061
FDA OKs generic version of J&J's antibiotic Levaquin from 12 manufacturers
Yahoo/AP
Monday, June 20, 2011 - 7:00pm
tags:
generics, FDA, antibiotics, JNJ, Ortho-McNeil-Janssen
Appeals Court Rejects Merck Effort to Recover Taxes, CNBC Says
Bloomberg
Monday, June 20, 2011 - 6:58pm
tags:
Merck, taxes
Roche preps vismodegib app after Ph2 skin cancer success
Fierce Biotech
Monday, June 20, 2011 - 11:57am
tags:
Roche, skin cancer, vismodegib
Icahn aims at longtime Forest CEO in shake-up bid
Yahoo/Reuters
Monday, June 20, 2011 - 11:48am
tags:
Carl Icahn, Forest Labs, Howard Solomon
Life Technologies Rejected by Supreme Court, Allowing Enzo Suit
Bloomberg
Monday, June 20, 2011 - 11:17am
tags:
Enzo, Life Technologies, Supreme Court
Patent Cliff Losses Mean Eli Lilly Must Acquire or Be Acquired
BNET Pharma
Monday, June 20, 2011 - 11:08am
tags:
patents, Eli Lilly, M&A
Biogen jumps on analyst upgrade
Marketwatch
Monday, June 20, 2011 - 11:06am
tags:
Biogen Idec
Pfizer's Idea to Fix the Drug Development Crisis, Which Probably Won't Work (But Just Might)
Motley Fool
Monday, June 20, 2011 - 10:58am
tags:
Pfizer, drug development
Pfizer Rejected By U.S. High Court on $58 Million Prempro Award
Bloomberg
Monday, June 20, 2011 - 10:57am
tags:
Pfizer, Wyeth, Prempro, Premarin
Watson Temporarily Barred From Selling Generic Seasonique
Bloomberg
Monday, June 20, 2011 - 10:55am
tags:
Watson Pharmaceuticals, generics, Seasonique, Teva Pharmaceuticals, Duramed, birth control pill
What FDA's Delay of Probuphine Trial Means for Titan Pharmaceuticals
Seeking Alpha
Monday, June 20, 2011 - 10:05am
tags:
FDA, Probuphine, Titan, Vanda, Novartis
Prolor Biotech: Interim Phase 2 Data Promising
Seeking Alpha
Monday, June 20, 2011 - 10:04am
tags:
Prolor, human growth hormone
8 Potential Biotech Acquisition Candidates
Seeking Alpha
Monday, June 20, 2011 - 9:30am
tags:
biotech, M&A, Arena Pharmaceuticals, Biomarin, Dendreon, Human Genome Sciences, Keryx, MannKind, Novartis, Orexigen, Vivus
Mylan wins on summary judgment
Bizjournals.com
Monday, June 20, 2011 - 9:27am
tags:
Mylan, Teva Pharmaceuticals, MS, multiple sclerosis, Copaxone
United Therapeutics licenses Pluristem lung disease treatment in deal that could top $55M
Yahoo/AP
Monday, June 20, 2011 - 9:26am
tags:
United Therapeutics, Pluristem, PAH
Pfizer, Acura Announce FDA Approval of Oxecta
Bloomberg
Monday, June 20, 2011 - 9:17am
tags:
Acura Pharmaceuticals, Pfizer, FDA, Oxecta, oxycodone
J&J Chief Working to Put Consent Decree in Past, FT Says
Bloomberg
Monday, June 20, 2011 - 9:15am
tags:
William Weldon, JNJ, consent decree, Pharma CEOs

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline
Defluorination is Happening Inside You Right Now
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.